ES2587507T3 - Fracción de Plectranthus amboinicus con actividad antiartrítica - Google Patents

Fracción de Plectranthus amboinicus con actividad antiartrítica Download PDF

Info

Publication number
ES2587507T3
ES2587507T3 ES12401234.5T ES12401234T ES2587507T3 ES 2587507 T3 ES2587507 T3 ES 2587507T3 ES 12401234 T ES12401234 T ES 12401234T ES 2587507 T3 ES2587507 T3 ES 2587507T3
Authority
ES
Spain
Prior art keywords
plectranthus amboinicus
fraction
solvent
antiarthritic activity
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12401234.5T
Other languages
English (en)
Inventor
Feng-Nien Ko
Jen-Wei Chen
Wen-Ling Yang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ONENESS BIOTECH Co
Original Assignee
ONENESS BIOTECH Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ONENESS BIOTECH Co filed Critical ONENESS BIOTECH Co
Application granted granted Critical
Publication of ES2587507T3 publication Critical patent/ES2587507T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Un extracto de Plectranthus amboinicus (Lour.) Spreng con enriquecimiento de la actividad antiartrítica preparado por un procedimiento que comprende los pasos siguientes: (a) extraer Plectranthus amboinicus (Lour.) Spreng con una solución alcohólica para obtener un extracto bruto; (b) eluir el extracto bruto por una cromatografía de fase normal usando hexano como un primer disolvente y hexano/acetato de etilo como un segundo disolvente para obtener un eluato del segundo disolvente.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
Tabla 8 Inhibición de diversos extractos a la liberación de IL-5 de PBMCs inducida por PHA
Concentración de la muestra (ug/ml)
Muestra
5 10 20 40
Ejemplo 2_ON-022
155,3 156,0 127,6 78,9
Ejemplo 2_ON-023
168,5 156,7 115,8 37,0
Ejemplo 1_ON-024
147,7 140,8 117,9 37,0
Ejemplo 1_ON-025
183,1 184,5 228,4 109,5
Ejemplo 3_ON-065
140,8 112,3 74,0 37,0
Ejemplo 3_ON-065
54,4 163,7 185,2 58,6
14

Claims (1)

  1. imagen1
ES12401234.5T 2011-11-22 2012-11-20 Fracción de Plectranthus amboinicus con actividad antiartrítica Active ES2587507T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TW100142840 2011-11-22
TW100142840A TWI501772B (zh) 2011-11-22 2011-11-22 具抗關節炎活性的到手香精萃物

Publications (1)

Publication Number Publication Date
ES2587507T3 true ES2587507T3 (es) 2016-10-25

Family

ID=47355988

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12401234.5T Active ES2587507T3 (es) 2011-11-22 2012-11-20 Fracción de Plectranthus amboinicus con actividad antiartrítica

Country Status (7)

Country Link
US (3) US20130131159A1 (es)
EP (1) EP2596798B1 (es)
JP (1) JP6290531B2 (es)
KR (1) KR101759751B1 (es)
CN (1) CN103127215B (es)
ES (1) ES2587507T3 (es)
TW (1) TWI501772B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI663982B (zh) * 2013-09-03 2019-07-01 合一生技股份有限公司 到手香萃取物用於製備具抗微生物功效組合物之用途
US10390720B2 (en) 2014-07-17 2019-08-27 Medtronic, Inc. Leadless pacing system including sensing extension
US9399140B2 (en) 2014-07-25 2016-07-26 Medtronic, Inc. Atrial contraction detection by a ventricular leadless pacing device for atrio-synchronous ventricular pacing
WO2016033802A1 (zh) * 2014-09-05 2016-03-10 合一生技股份有限公司 类黄酮化合物在制备伤口愈合组合物的用途
US9492669B2 (en) 2014-11-11 2016-11-15 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9623234B2 (en) 2014-11-11 2017-04-18 Medtronic, Inc. Leadless pacing device implantation
US9492668B2 (en) 2014-11-11 2016-11-15 Medtronic, Inc. Mode switching by a ventricular leadless pacing device
US9724519B2 (en) 2014-11-11 2017-08-08 Medtronic, Inc. Ventricular leadless pacing device mode switching
US9289612B1 (en) 2014-12-11 2016-03-22 Medtronic Inc. Coordination of ventricular pacing in a leadless pacing system
US11207527B2 (en) 2016-07-06 2021-12-28 Cardiac Pacemakers, Inc. Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system
WO2018014805A1 (en) * 2016-07-17 2018-01-25 ONENESS BIOTECH CO., Ltd Topical formulation for promoting wound healing
CN107739306B (zh) * 2017-09-11 2021-02-09 湖南鑫利生物科技有限公司 一种制备精制迷迭香提取物的加工方法
US11826395B2 (en) 2021-06-28 2023-11-28 Oneness Biotech Co., Ltd. Methods for preparation of Plectranthus amboinicus extracts
WO2023227087A1 (en) * 2022-05-27 2023-11-30 Oneness Biotech Co., Ltd. Plectranthus amboinicus extract for use in inhibiting immune responses
US11839636B1 (en) * 2022-07-27 2023-12-12 Babry Oren Pharmaceutical composition based on plant raw materials: #2.1

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101068559B (zh) 2004-07-23 2011-08-31 福生生物科技股份有限公司 红球姜的抗超敏炎症和抗敏活性
US20070259057A1 (en) * 2004-08-30 2007-11-08 Kao Corporation Wrinkle Reduction Agent, Lipolysis Accelerator, Composition for External Use on Skin, and Food or Beverage Composition
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
TWI361074B (en) * 2005-12-22 2012-04-01 Dev Center Biotechnology Plant extracts for enhancing healing of wounds,and the preparation process and use thereof
TWI320714B (en) * 2006-09-15 2010-02-21 Dev Center Biotechnology Plant extracts for the treatment of rheumatoid arthritis
EP1925310B1 (en) * 2006-11-24 2015-03-25 Development Center For Biotechnology Plant extracts from Plectranthus and Centella for treating skin disorders and accelerating wound healing in diabetic patients
EP2025340A1 (en) * 2007-08-14 2009-02-18 Development Center For Biotechnology Plant extracts for the treatment of rheumatoid arthritis
JP4606444B2 (ja) * 2007-08-21 2011-01-05 アピ株式会社 アントシアニン含有経口投与用組成物及びその製造方法
US8449924B2 (en) * 2007-08-29 2013-05-28 Development Center For Biotechnology Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds
AU2008302356A1 (en) * 2007-09-17 2009-03-26 Academia Sinica Compositions and methods for treating inflammation and inflammation-related disorders by Plectranthus Amboinicus extracts
MX2010009314A (es) * 2008-02-25 2010-09-24 Nestec Sa Polifenoles para el tratamiento de padecimientos de cartilago.
JP2011079800A (ja) * 2009-10-09 2011-04-21 Kitasato Institute 抗インフルエンザウイルス剤

Also Published As

Publication number Publication date
CN103127215A (zh) 2013-06-05
EP2596798A1 (en) 2013-05-29
US20140322365A1 (en) 2014-10-30
US20130131159A1 (en) 2013-05-23
KR20130056842A (ko) 2013-05-30
EP2596798B1 (en) 2016-06-01
US20170354701A1 (en) 2017-12-14
TWI501772B (zh) 2015-10-01
JP6290531B2 (ja) 2018-03-07
JP2013107888A (ja) 2013-06-06
CN103127215B (zh) 2017-11-14
KR101759751B1 (ko) 2017-07-31
TW201321010A (zh) 2013-06-01
US11517604B2 (en) 2022-12-06

Similar Documents

Publication Publication Date Title
ES2587507T3 (es) Fracción de Plectranthus amboinicus con actividad antiartrítica
ES2691070T3 (es) Péptidos antiinflamatorios y composición que comprende los mismos
CU20130137A7 (es) Derivados de ácido 3- fenilpropiónico ramificados y su uso
CR20120215A (es) Anticuerpos contra csf-1r humano y usos de los mismos
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
BR112016008576A2 (pt) Formulações aquosas estáveis de anticorpos e forma farmacêutica de dosagem unitária
NI201600014A (es) Compuestos y composiciones como inhibidores de la mek.
CL2013003144A1 (es) Composicion que comprende a) extracto de arroz fermentado con monascus purpureus, b) un acido graso omega, c) l-carnitina y uno o mas de los siguientes: d) al menos un policosanol, e) resveratrol, f) coenzima q10 y g) al menos una vitamina, util como anticolesterolemico y antitrigliceridemico y para aumentar el colesterol hdl.
CL2010001587A1 (es) Proceso de preparacion de un concentrado de etil esteres de acidos grasos omega-3 que comprende sobre el 80% en peso de dichos esteres en configuracion cis y sus dobles enlaces separados por una unidad metilenica.
JP2011136976A5 (es)
ES2425294B1 (es) Compuestos derivados de sulforafano, método de obtención y su uso médico, alimenticio y cosmético
ES2403549R1 (es) Co-cristales de agomelatina con formadores de co-cristales
BR112012019277A2 (pt) processo para produção de um solvente de acetato de etila e coprodução de etanol
WO2012093919A3 (ko) 백혈병 치료용 조성물 및 몰약 추출물의 제조방법
Yi Relationship between floral scent of the major nectar source plants and their flower visitors in Changbai Mountain region
Wei et al. Chemical constituents from rhizome of Daphne papyracea var. crassiuscula
IN2015CH04779A (es)
MX364272B (es) PROCESO DE OBTENCION DEL EUDESMANO SESQUITERPENO 4A-CINNAMOILOXI-1ß,3A-DIHIDROXIEUDESM-7,8-ENO(4CDE).
GR1008312B (el) Παραγωγη εμπορικου προϊοντος αλκοολουχου ποτου απο συκα με την ονομασια "σουμα".
EP2210593A3 (en) Tablettable formulations of vitamin A and derivatives thereof
Gholkar et al. Article Details A Novel Method For Isolation of Mangiferin from Mangifera Indica L. Bark
TH168092A (th) องค์ประกอบเครื่องสำอางที่ประกอบด้วยน้ำส้มสายชูมินท์ดังส่วนประกอบออกฤทธิ์
LI et al. Chemical constituents of rhizomas Acori Calami from Hunan Province
PL413953A1 (pl) Sposób wytwarzania czystego optycznie (+)-(R)-7-hydroksyflawanonu
PL404783A1 (pl) Sposób enzymatycznego rozdziału racemicznej pochodnej α-etyloseryny